Guangdong Transtek Medical Electronics Co.,Ltd.

On May 21, Transtek Medical (300562.SZ) and Ping An Health officially signed a strategic cooperation agreement in Zhongshan, marking the launch of a joint initiative to establish a comprehensive "prevention–monitoring–intervention" health management...

Transtek recently hosted a successful roundtable in Yunnan under the theme "Prevention, Interruption, and Reversal of Heart Disease," bringing together renowned international experts and healthcare innovators to explore the future of cardiovascular care.

On March 28, 2025, Transtek Medical(stock code: [300562.SZ]) announced its 2024 annual results, reporting solid growth across key financial metrics.

To enhance public company sentiment management and investor relations while fostering media communication and industry collaboration, the Guangdong Listed Companies Association, in partnership with Securities Times, organized a special exchange event at..

Transtek Medical is proud to introduce its latest innovation in remote patient monitoring: the 4G Pulse Oximeter.

We are proud to announce that Transtek Medical has successfully obtained the Medical Device Single Audit Program (MDSAP) certification for our blood glucose meters.

At the start of the new year, Transtek Medical (300562.SZ) celebrates a double victory.

Leading Provider of Devices and Device solutions Transtek Medical's product range includes cellular blood pressure monitors, weight scales blood glucose monitors and pulse oximeters.

On January 15th, Transtek Medical (300562.SZ) successfully held its 2025 New Year Gala & 8th Anniversary of Public Listing Celebration in Zhongshan, Guangdong.

On December 18, 2024, the WIM2024 Innovators Annual Conference, hosted by EqualOcean, was held in Beijing.